Data sharing uncovers five new risk genes for Alzheimer’s disease

Analysis of genetic data from more than 94,000 individuals has revealed five new risk genes for Alzheimer’s diseas...

March 4, 2019 | Monday | News
Rakuten Aspyrian changes name to Rakuten Medical

Rakuten Aspyrian, a biotechnology company developing precision-targeted cancer therapies based on its proprietary Photoi...

March 1, 2019 | Friday | News
Agilent announces new Library Prep System for NGS

Agilent Technologies, Inc. recently announced a new next-generation sequencing (NGS) library preparation system designed...

March 1, 2019 | Friday | News
MTS to help medical device companies for 3D-Printed Spinal Implants

MTS Systems Corporation, a leading global supplier of high-performance test systems, motion simulators and sensors, anno...

February 28, 2019 | Thursday | News
Amicus begins global research and gene therapy centre of excellence

Amicus Therapeutics is establishing a new Global Research and Gene Therapy centre of Excellence in&n...

February 28, 2019 | Thursday | News
Axial Biotherapeutics raises $25M in series b financing

Axial Biotherapeutics, a biotechnology company building a unique class of gut-targeted programs for neurodegenerative an...

February 28, 2019 | Thursday | News
The CoWrks Foundry partners with Yale University

To address growing health and social disparities in India and around the globe, The CoWrks Foundry has partnered with Ya...

February 28, 2019 | Thursday | News
Bausch Health to acquire assets of Synergy Pharma

Bausch Health Companies Inc. has announced that the Company was selected as the successful bidder to acquire certain ass...

February 27, 2019 | Wednesday | News
Gain Therapeutics SA announces funding support from a leading Parkinson's Research Foundation

Gain Therapeutics SA, a biotechnology company discovering and developing novel therapeutics to target lysosomal enzymes ...

February 26, 2019 | Tuesday | News
HOOKIPA Pharma raises $37.4M in Series D Financing

HOOKIPA Pharma, a clinical stage biopharmaceutical company developing a new class of immunotherapeutics targeting infect...

February 26, 2019 | Tuesday | News
Marinomed receives EUR 15M EIB financing

The European Investment Bank (EIB) is providing EUR 15 million to Marinomed Biotech AG, a Vienna- based Biopharmaceutica...

February 26, 2019 | Tuesday | News
FDA & Flatiron Health expand Data Cancer Research collaboration

Flatiron Health and the Information Exchange and Data Transformation (INFORMED) Program at the U.S. Food and Drug Admini...

February 27, 2019 | Wednesday | News
Novartis to license Akcea-Ionis cardiac disease drug

Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals announced that Novartis has exercised its option to licen...

February 26, 2019 | Tuesday | News
Exicure announces dosing of first patient in Ph1b/2 immuno-oncology trial

Exicure, a clinical stage biotechnology company developing a new class of immunomodulatory and gene regulating drug...

February 25, 2019 | Monday | News
GE to sell Biopharma business for $21.4B to Danaher

GE has announced a definitive agreement to sell its BioPharma business to Danaher Corporation for a total consideration ...

February 26, 2019 | Tuesday | News
Sysmex Inostics’ OncoBEAM shows superior performance in mutation detection for HCC

Data recently published in Clinical Cancer Research demonstrate the advantages of using an ultra-high sensitiv...

February 25, 2019 | Monday | News
EC approves Pfizer's ZIRABEV, a biosimilar to Avastin

Pfizer recently announced that the European Commission (EC) has approved ZIRABEV for the treatment of metastatic ca...

February 25, 2019 | Monday | News
Roche to acquire Spark Therapeutics for $ 4.3B

Roche and Spark Therapeutics have entered into a definitive merger agreement for Roche to fully acquire Spark Therapeuti...

February 25, 2019 | Monday | News